Literature DB >> 23872946

DPY30 regulates pathways in cellular senescence through ID protein expression.

Elisabeth Simboeck1, Arantxa Gutierrez, Luca Cozzuto, Malte Beringer, Livia Caizzi, William M Keyes, Luciano Di Croce.   

Abstract

Cellular senescence is an intrinsic defense mechanism to various cellular stresses: while still metabolically active, senescent cells stop dividing and enter a proliferation arrest. Here, we identify DPY30, a member of all mammalian histone H3K4 histone methyltransferases (HMTases), as a key regulator of the proliferation potential of human primary cells. Following depletion of DPY30, cells show a severe proliferation defect and display a senescent phenotype, including a flattened and enlarged morphology, elevated level of reactive oxygen species (ROS), increased SA-β-galactosidase activity, and formation of senescence-associated heterochromatin foci (SAHFs). While DPY30 depletion leads to a reduced level of H3K4me3-marked active chromatin, we observed a concomitant activation of CDK inhibitors, including p16INK4a, independent of H3K4me3. ChIP experiments show that key regulators of cell-cycle progression, including ID proteins, are under direct control of DPY30. Because ID proteins are negative regulators of the transcription factors ETS1/2, depletion of DPY30 leads to the transcriptional activation of p16INK4a by ETS1/2 and thus to a senescent-like phenotype. Ectoptic re-introduction of ID protein expression can partially rescue the senescence-like phenotype induced by DPY30 depletion. Thus, our data indicate that DPY30 controls proliferation by regulating ID proteins expression, which in turn lead to senescence bypass.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23872946      PMCID: PMC3746196          DOI: 10.1038/emboj.2013.159

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  57 in total

1.  Genome-wide mapping of Polycomb target genes unravels their roles in cell fate transitions.

Authors:  Adrian P Bracken; Nikolaj Dietrich; Diego Pasini; Klaus H Hansen; Kristian Helin
Journal:  Genes Dev       Date:  2006-04-17       Impact factor: 11.361

2.  Molecular regulation of H3K4 trimethylation by ASH2L, a shared subunit of MLL complexes.

Authors:  Melissa M Steward; Jung-Shin Lee; Aisling O'Donovan; Matt Wyatt; Bradley E Bernstein; Ali Shilatifard
Journal:  Nat Struct Mol Biol       Date:  2006-08-06       Impact factor: 15.369

3.  Protein interactions within the Set1 complex and their roles in the regulation of histone 3 lysine 4 methylation.

Authors:  Pierre-Marie Dehé; Bernhard Dichtl; Daniel Schaft; Assen Roguev; Mercè Pamblanco; Régine Lebrun; Alfonso Rodríguez-Gil; Msau Mkandawire; Katarina Landsberg; Anna Shevchenko; Andrej Shevchenko; Lorena E Rosaleny; Vicente Tordera; Sebastián Chávez; A Francis Stewart; Vincent Géli
Journal:  J Biol Chem       Date:  2006-08-18       Impact factor: 5.157

4.  PTIP associates with MLL3- and MLL4-containing histone H3 lysine 4 methyltransferase complex.

Authors:  Young-Wook Cho; Teresa Hong; Sunhwa Hong; Hong Guo; Hong Yu; Doyeob Kim; Tad Guszczynski; Gregory R Dressler; Terry D Copeland; Markus Kalkum; Kai Ge
Journal:  J Biol Chem       Date:  2007-05-11       Impact factor: 5.157

Review 5.  A COMPASS in the voyage of defining the role of trithorax/MLL-containing complexes: linking leukemogensis to covalent modifications of chromatin.

Authors:  Kristen Tenney; Ali Shilatifard
Journal:  J Cell Biochem       Date:  2005-06-01       Impact factor: 4.429

6.  E2F-1 is a critical modulator of cellular senescence in human cancer.

Authors:  Chaehwa Park; Inkyoung Lee; Won Ki Kang
Journal:  Int J Mol Med       Date:  2006-05       Impact factor: 4.101

7.  Bypass of senescence by the polycomb group protein CBX8 through direct binding to the INK4A-ARF locus.

Authors:  Nikolaj Dietrich; Adrian P Bracken; Emmanuelle Trinh; Charlotte K Schjerling; Haruhiko Koseki; Juri Rappsilber; Kristian Helin; Klaus H Hansen
Journal:  EMBO J       Date:  2007-03-01       Impact factor: 11.598

8.  Characterization and crystallization of human DPY-30-like protein, an essential component of dosage compensation complex.

Authors:  Xiuhua Dong; Yong Peng; Ying Peng; Feng Xu; Xiaojing He; Feng Wang; Xiaozhong Peng; Boqin Qiang; Jiangang Yuan; Zihe Rao
Journal:  Biochim Biophys Acta       Date:  2005-08-30

9.  Quantitative dissection and stoichiometry determination of the human SET1/MLL histone methyltransferase complexes.

Authors:  Rick van Nuland; Arne H Smits; Paschalina Pallaki; Pascal W T C Jansen; Michiel Vermeulen; H T Marc Timmers
Journal:  Mol Cell Biol       Date:  2013-03-18       Impact factor: 4.272

10.  The Polycomb group proteins bind throughout the INK4A-ARF locus and are disassociated in senescent cells.

Authors:  Adrian P Bracken; Daniela Kleine-Kohlbrecher; Nikolaj Dietrich; Diego Pasini; Gaetano Gargiulo; Chantal Beekman; Kim Theilgaard-Mönch; Saverio Minucci; Bo T Porse; Jean-Christophe Marine; Klaus H Hansen; Kristian Helin
Journal:  Genes Dev       Date:  2007-03-01       Impact factor: 11.361

View more
  17 in total

1.  Molecular basis for DPY-30 association to COMPASS-like and NURF complexes.

Authors:  Véronique Tremblay; Pamela Zhang; Chandra-Prakash Chaturvedi; Janet Thornton; Joseph S Brunzelle; Georgios Skiniotis; Ali Shilatifard; Marjorie Brand; Jean-François Couture
Journal:  Structure       Date:  2014-11-20       Impact factor: 5.006

2.  Hijacking a key chromatin modulator creates epigenetic vulnerability for MYC-driven cancer.

Authors:  Zhenhua Yang; Kushani Shah; Theodore Busby; Keith Giles; Alireza Khodadadi-Jamayran; Wei Li; Hao Jiang
Journal:  J Clin Invest       Date:  2018-07-23       Impact factor: 14.808

3.  The DPY30 subunit in SET1/MLL complexes regulates the proliferation and differentiation of hematopoietic progenitor cells.

Authors:  Zhenhua Yang; Jonathan Augustin; Chenbei Chang; Jing Hu; Kushani Shah; Chia-Wei Chang; Tim Townes; Hao Jiang
Journal:  Blood       Date:  2014-08-18       Impact factor: 22.113

4.  Specific inhibition of DPY30 activity by ASH2L-derived peptides suppresses blood cancer cell growth.

Authors:  Kushani K Shah; Robert H Whitaker; Theodore Busby; Jing Hu; Bi Shi; Zhenjia Wang; Chongzhi Zang; William J Placzek; Hao Jiang
Journal:  Exp Cell Res       Date:  2019-06-26       Impact factor: 3.905

5.  Early transcriptional events linked to induction of diapause revealed by RNAseq in larvae of drosophilid fly, Chymomyza costata.

Authors:  Rodolphe Poupardin; Konrad Schöttner; Jaroslava Korbelová; Jan Provazník; David Doležel; Dinko Pavlinic; Vladimír Beneš; Vladimír Koštál
Journal:  BMC Genomics       Date:  2015-09-21       Impact factor: 3.969

6.  Roles of DPY30 in the Proliferation and Motility of Gastric Cancer Cells.

Authors:  Yong Joo Lee; Myoung-Eun Han; Su-Jin Baek; Seon-Young Kim; Sae-Ock Oh
Journal:  PLoS One       Date:  2015-07-06       Impact factor: 3.240

7.  p16INK4a in cellular senescence.

Authors:  Elisabeth Simboeck; Luciano Di Croce
Journal:  Aging (Albany NY)       Date:  2013-08       Impact factor: 5.682

8.  A SET-domain-independent role of WRAD complex in cell-cycle regulatory function of mixed lineage leukemia.

Authors:  Aamir Ali; Sailaja Naga Veeranki; Shweta Tyagi
Journal:  Nucleic Acids Res       Date:  2014-05-31       Impact factor: 16.971

9.  Id1 expression in kidney endothelial cells protects against diabetes-induced microvascular injury.

Authors:  Shree Sharma; Matthew Plotkin
Journal:  FEBS Open Bio       Date:  2020-06-26       Impact factor: 2.693

10.  Novel SPAST deletion and reduced DPY30 expression in a Spastic Paraplegia type 4 kindred.

Authors:  Loretta Racis; Eugenia Storti; Maura Pugliatti; Virgilio Agnetti; Alessandra Tessa; Filippo M Santorelli
Journal:  BMC Med Genet       Date:  2014-04-01       Impact factor: 2.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.